Drug
Esketamine group
Esketamine group is a pharmaceutical drug with 6 clinical trials. Currently 4 active trials ongoing.
Total Trials
6
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Active Trials
4(67%)
Phase Distribution
Ph phase_4
1
17%
Ph not_applicable
5
83%
Phase Distribution
0
Early Stage
0
Mid Stage
1
Late Stage
Phase Distribution6 total trials
Phase 4Post-market surveillance
1(16.7%)
N/ANon-phased studies
5(83.3%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
4
trials recruiting
Total Trials
6
all time
Status Distribution
Active(6)
Detailed Status
Recruiting4
Not yet recruiting2
Development Timeline
Analytics
Development Status
Total Trials
6
Active
4
Success Rate
N/A
Most Advanced
Phase 4
Trials by Phase
Phase 41 (16.7%)
N/A5 (83.3%)
Trials by Status
not_yet_recruiting233%
recruiting467%
Recent Activity
4 active trials
Showing 5 of 6
recruitingnot_applicable
Application of Remimazolam, Dexmedetomidine, and Esketamine in Pediatric Preoperative Sedation
NCT07050212
recruitingphase_4
Comparative Effectiveness Study of Two Forms of Ketamine for Treatment-resistant Depression
NCT06278779
recruitingnot_applicable
Esketamine Combined Pulsed Radiofrequency for Acute/Subacute Zoster-associated Trigeminal Neuralgia
NCT06890897
recruitingnot_applicable
Esketamine Combined Pregabalin and Duloxetine for Postherpetic Neuralgia
NCT06896994
not_yet_recruitingnot_applicable
Esketamine Combined With PRF of DRG for Acute/Subacute Zoster-associated Pain
NCT06914206
Clinical Trials (6)
Showing 6 of 6 trials
NCT07050212Not Applicable
Application of Remimazolam, Dexmedetomidine, and Esketamine in Pediatric Preoperative Sedation
NCT06278779Phase 4
Comparative Effectiveness Study of Two Forms of Ketamine for Treatment-resistant Depression
NCT06890897Not Applicable
Esketamine Combined Pulsed Radiofrequency for Acute/Subacute Zoster-associated Trigeminal Neuralgia
NCT06896994Not Applicable
Esketamine Combined Pregabalin and Duloxetine for Postherpetic Neuralgia
NCT06914206Not Applicable
Esketamine Combined With PRF of DRG for Acute/Subacute Zoster-associated Pain
NCT06914180Not Applicable
Esketamine Combined With PRF for Trigeminal Postherpetic Neuralgia
All 6 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 6